These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30428263)

  • 1. Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.
    Daniel-Wayman S; Abate G; Barber DL; Bermudez LE; Coler RN; Cynamon MH; Daley CL; Davidson RM; Dick T; Floto RA; Henkle E; Holland SM; Jackson M; Lee RE; Nuermberger EL; Olivier KN; Ordway DJ; Prevots DR; Sacchettini JC; Salfinger M; Sassetti CM; Sizemore CF; Winthrop KL; Zelazny AM
    Am J Respir Crit Care Med; 2019 Apr; 199(8):947-951. PubMed ID: 30428263
    [No Abstract]   [Full Text] [Related]  

  • 2. [To improve diagnosis and treatment of nontuberculous mycobacterial diseases in China].
    Tang SJ; Li L
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Jan; 44(1):1-3. PubMed ID: 33412616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
    Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
    Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nontuberculous Mycobacterial Infections in Children.
    Bhattacharya J; Mohandas S; Goldman DL
    Pediatr Rev; 2019 Apr; 40(4):179-190. PubMed ID: 30936399
    [No Abstract]   [Full Text] [Related]  

  • 5. Nontuberculous mycobacterial disease in childhood - update on diagnostic approaches and treatment.
    Zimmermann P; Curtis N; Tebruegge M
    J Infect; 2017 Jun; 74 Suppl 1():S136-S142. PubMed ID: 28646953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontuberculous Mycobacterial Infections.
    Desai AN; Hurtado R
    JAMA; 2021 Apr; 325(15):1574. PubMed ID: 33877273
    [No Abstract]   [Full Text] [Related]  

  • 7. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of slowly growing mycobacteria.
    Philley JV; Griffith DE
    Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 10. What is Nontuberculous Mycobacteria (NTM) Disease?
    Campo M
    Am J Respir Crit Care Med; 2017 May; 195(9):P17-P18. PubMed ID: 28459317
    [No Abstract]   [Full Text] [Related]  

  • 11. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
    Ruth MM; van Ingen J
    Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416
    [No Abstract]   [Full Text] [Related]  

  • 12. The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.
    Baldwin SL; Larsen SE; Ordway D; Cassell G; Coler RN
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007083. PubMed ID: 30763316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated infection with Mycobacterium tilburgii in a male immunocompromised patient.
    Temmerman S; Vandekerckhove L; Sermijn E; Vogelaers D; Claeys G; Vaneechoutte M; Cools P; Callens S
    J Clin Microbiol; 2014 May; 52(5):1777-9. PubMed ID: 24523470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical mycobacteria: an important differential for the general physician.
    Rahama O; Thaker H
    Clin Med (Lond); 2013 Oct; 13(5):504-6. PubMed ID: 24115711
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
    Philley JV; Griffith DE
    Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
    Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
    Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
    [No Abstract]   [Full Text] [Related]  

  • 19. Autophagy and Host Defense in Nontuberculous Mycobacterial Infection.
    Silwal P; Kim IS; Jo EK
    Front Immunol; 2021; 12():728742. PubMed ID: 34552591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Tuberculosis and Nontuberculous Mycobacterial Infections at a National Specialized Hospital in China.
    Mei Y; Zhang W; Shi Y; Jiang H; Chen Z; Chokkakula S; Long S; Pan C; Wang H
    Acta Derm Venereol; 2019 Oct; 99(11):997-1003. PubMed ID: 31396633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.